jacobus pharmaceuticals
May 07, 2019
Notizia
Roche's takes a step- forward to treat Huntington's disease A new drug co-developed by Roche and Ionis Pharmaceuticals can be a potential candidate to treat Huntington's disease. RG6042 which is an antisense oligonucleotide is able to successfully lower down the production of a toxic protein that results in dysf...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
